Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Blocking interferon-gamma might help treat various autoimmune diseases.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Combining platelet-rich plasma injections and gel may effectively treat morphea, improving skin elasticity and reducing pain.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Superficial cryotherapy significantly improves eyebrow hair growth in alopecia universalis patients.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

A man developed skin issues from cancer medication, which improved with specific treatments.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Enhancing Tregs can protect against alopecia areata.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.